ATGE — Stock Film
STOCK FILMSCENE 1/12ATGE · $107
Stock Expert AI presents
ATGE
Adtalem Global Education Inc
~4 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Adtalem Global Education Inc. What it actually does.

Provides degree and non-degree programs in nursing and health professions through Chamberlain University. Now — the numbers.

on the stock market since 1991
4,624 employees
$3.9B market value
WHERE DOES THE MONEY COME FROM?
41%Walden University
Walden UniversityChamberlain 38%Medical and Veterinary 20%
41% of all revenue comes from a single line: Walden University.

Revenue is spread across several lines; no single product carries the company.

Revenue last year:
$2B
The net profit left over:
$251.6M
Out of every $100 in sales, $13 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 13%

This is an established company with proven profits.

THE SALES TREND
Sales are growing, year after year.

Average growth of 9% a year over the last 4 years. Every year shown ended in profit.

$1.4B
2022
2023
2024
2025
$2B
2026
Cash on hand:
$406.3M
Total debt:
$905.5M
The debt outweighs the cash.

The gap is $499.2M. In times of high interest rates, a gap like that can squeeze a company.

Every quarter, analysts set a profit bar.
How many of the last 8 did the company clear?
8 / 8
EXPECTATIONS MET OR BEATEN
8
May 2024
Jan 2026
8 TIMES IN THE LAST 8 QUARTERS
It clears the bar, quarter after quarter.
THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking8/10
The shares trade freely10/10
WEAK SPOTS
The stock has lost its spark3/10
THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 31% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/2
Sales keep climbing

Over the last 4 years, sales grew about 9% a year on average.

2
THE BRIGHT SIDE · 2/2
Delivers on expectations

It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.

1
THE RISKS · 1/2
The price sits above analysts’ target

The stock trades 13% above the average analyst price target.

2
THE RISKS · 2/2
The stock has lost its spark

Since the drop from its peak, buyer appetite hasn’t come back. Council score: 3/10.

FINALE · THE GRADE
grade pending

We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 12, 2026 · stockexpertai.com · Stock Film